|1.||Martina, Byron E E: 1 article (07/2008)|
|2.||Rimmelzwaan, Guus F: 1 article (07/2008)|
|3.||Koraka, Penelopie: 1 article (07/2008)|
|4.||Haagmans, Bart L: 1 article (07/2008)|
|5.||van den Doel, Petra: 1 article (07/2008)|
|6.||Osterhaus, Albert D M E: 1 article (07/2008)|
11/15/1995 - "Furthermore, inhibition of tumor growth by B956 is shown to be correlated with inhibition of ras posttranslational processing in the tumor. "
01/01/1997 - "Methyl ester prodrug of B956 and B1352 showed antitumor activity in ras mutated human tumor xenograft model. "
11/15/1995 - "Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956."
11/15/1995 - "B956/B1086 at 100 mg/kg also inhibited tumor growth by EJ-1 human bladder carcinoma, HT1080 human fibrosarcoma, and to a lesser extent by HCT116 human colon carcinoma xenografts in nude mice. "
07/01/2008 - "Furthermore, WNV can productively infect cultured human dendritic cells (DCs) and infection of dendritic cells with the glycosylated WNV-NY99 L1 strain induced production of significantly more TNF-alpha and IFN-alpha in cultured DC, than infection with the non-glycosylated B956 L2 strain. "
|1.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|1.||Heterologous Transplantation (Xenotransplantation)